Results 71 to 80 of about 192,978 (193)

Integrated Management of Cardiovascular–Renal–Hepatic–Metabolic Syndrome: Expanding Roles of SGLT2is, GLP-1RAs, and GIP/GLP-1RAs

Biomedicines
Cardiovascular–Kidney–Metabolic syndrome, introduced by the American Heart Association in 2023, represents a complex and interconnected spectrum of diseases driven by shared pathophysiological mechanisms.
Nikolaos Theodorakis, Maria Nikolaou
doaj   +1 more source

Relevance of obesity-related organ damage and metabolic syndrome classification in cardiovascular and renal risk stratification in patients with essential hypertension

Frontiers in Cardiovascular Medicine
IntroductionHypertension is a relevant cardiovascular comorbidity. Adipose tissue represents a metabolically active tissue involved in the regulation of blood pressure and metabolic alterations.
Luigi Petramala, Antonietta Gigante, Francesca Sarlo, Adriana Servello, Francesco Circosta, Luca Marino, Luca Marino, Antonello Ciccarelli, Giuseppe Cavallaro, Giuseppe Cavallaro, Claudio Letizia   +10 more
doaj   +1 more source

Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study

Frontiers in Endocrinology
Background Cardiovascular disease (CVD) remains a major contributor to the global disease burden. Previous studies have established a link between the atherogenic index of plasma (AIP) and CVD.
Yu Zhang, Yue Song, Yinfei Lu, Tao Liu, Ping Yin   +4 more
semanticscholar   +1 more source

Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Chronic kidney disease (CKD) leads to premature mortality from cardiovascular events before kidney replacement therapy. Despite recognition of syndromes like cardiorenal anemia and cardiovascular‐kidney‐metabolic, predictive models for kidney ...
Shunsuke Inaba, Takanori Hasegawa, Yuta Nakano, Shotaro Naito, Rena Suzukawa, Takaaki Koide, Hisateru Sekiya, Hisazumi Matsuki, Tamami Fujiki, Hiroaki Kikuchi, Yohei Arai, Yutaro Mori, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Soichiro Iimori, Eisei Sohara, Shinichi Uchida, Shintaro Mandai   +18 more
doaj   +1 more source

Inverse Relationship Between Serum Carotenoid Levels and Cardiovascular‐Kidney‐Metabolic Syndrome Among the General Adult Population

Journal of Diabetes
To examine the relationship between serum carotenoid levels and cardiovascular‐kidney‐metabolic (CKM) syndrome in a representative sample of US adults.
Mengli Chen, Shuyue Cai, Qinfeng Jia, Yifang Suo, Yuan Tang, Yanping Shi, Xu Zhu, Haifeng Zhang   +7 more
semanticscholar   +1 more source

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes

Cardiovascular Diabetology
The 10th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on December 5–6, 2024.
Oliver Schnell, Jaime Almandoz, Lisa Anderson, Katharine Barnard-Kelly, Tadej Battelino, Matthias Blüher, Luca Busetto, Doina Catrinou, Antonio Ceriello, Xavier Cos, Thomas Danne, Colin M. Dayan, Stefano Del Prato, Beatriz Fernández-Fernández, Paola Fioretto, Thomas Forst, James R. Gavin, Francesco Giorgino, Per-Henrik Groop, Igor A. Harsch, Hiddo J. L. Heerspink, Lutz Heinemann, Mahmoud Ibrahim, Michel Jadoul, Sarah Jarvis, Linong Ji, Naresh Kanumilli, Mikhail Kosiborod, Ulf Landmesser, Sofia Macieira, Boris Mankovsky, Nikolaus Marx, Chantal Mathieu, Barbara McGowan, Tatjana Milenkovic, Othmar Moser, Dirk Müller-Wieland, Nikolaos Papanas, Dipesh C. Patel, Andreas F. H. Pfeiffer, Dario Rahelić, Helena W. Rodbard, Lars Rydén, Elke Schaeffner, C. Wendy Spearman, Alin Stirban, Frank Tacke, Pinar Topsever, Luc Van Gaal, Eberhard Standl   +49 more
doaj   +1 more source

Cardiovascular-kidney-metabolic syndrome: the interdisciplinary approach. A review

Terapevticheskii arkhiv
The revealed interrelationships between obesity, type 2 diabetes mellitus, cardiovascular diseases and chronic kidney disease are an important problem of modern healthcare worldwide, which is gradually becoming an epidemic. The study of these diseases in such a combination becomes the subject of discussion among scientists and the topic of various ...
openaire   +1 more source

Association between C-reactive protein-triglyceride glucose index and Future cardiovascular disease risk in a population with cardiovascular-Kidney-metabolic syndrome stage 0–3

Scientific Reports
Cardiovascular–Kidney–Metabolic (CKM) syndrome, a concept recently introduced by the American Heart Association (AHA), emphasizes the intricate relationships among metabolic, renal, and cardiovascular diseases. The C-reactive protein–triglyceride–glucose
Zhihui Lu, Long Li, Xiaolin Wang, Luo Lv, Shuling Rong, Bao Li   +5 more
doaj   +1 more source

Association of nephrolithiasis history with adverse outcomes in cardiovascular-kidney-metabolic syndrome. [PDF]

Ren Fail
Bi X, He Y, Shen Y, Shen Y, Shen A, Zhou S, Li X, Ding F, Nie S, Wang W.   +9 more
europepmc   +1 more source

Translational Lifestyle Medicine Approaches to Cardiovascular-Kidney-Metabolic Syndrome. [PDF]

Healthcare (Basel)
Papadakis Z.
europepmc   +1 more source